Celsius Lab Scale Solution
Smart condition setting, a genuine end-to-end integrated freeze-thaw system.
A robust, complete, and scalable solution for frozen storage and frozen transport. Sartorius offers lab-scale Celsius solutions for smarter and earlier process decisions in the management of frozen active pharmaceutical ingredients. The Celsius Lab-scale Platform enables the characterization of freezing and thawing within single-use bags of 30 mL to 100 mL, featuring complete scalability up to the commercial-scale Celsius Platform (CFT, FFT, and FFTP).
basic information
Make smart decisions with Celsius Lab Scale Solutions ▪ Compatibility Create models that accurately simulate the temperature profiles of various freeze/thaw technologies. ▪ Scalability Use the same relevant materials for all Celsius commercial scale solutions (Celsius CFT, FFT, FFTp) to ensure reproducible freeze/thaw conditions. ▪ Versatile environmental settings The Celsius platform enables rapid, economical, and adaptable frozen transport for process development through diverse solutions.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Related Videos
catalog（6）
Download All Catalogs
News about this product（5）
-
[End] Innovation Forum 2023 "Simplification of pDNA|mRNA Manufacturing Process by Sartorius"
This event has concluded. *Please note that there are currently no plans for on-demand distribution. mRNA pharmaceuticals are attracting attention as a new modality for drug discovery. Sartorius has a wide range of technologies that cover the mRNA manufacturing process, including E. coli culture, pDNA purification, IVT reactions, mRNA purification, and freeze storage. In this forum, we will provide a meaningful discussion platform centered around topics such as "pDNA|mRNA Manufacturing Processes," "Sartorius Manufacturing Platforms," and "Application Examples," inviting guest speakers to give presentations and facilitating questions and interactions from participants. Special Lecture Kazuhisa Uchida, Graduate School, Kobe University Capacity [In-person participation] 35 people *If there are many applications, a lottery will be held. [Online participation] 200 people *Please note that applications from competitors and research companies may be declined in advance.
-
[Sending recorded video] Bulk freezing process of pharmaceuticals using single-use technology.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Freezing, storage, transportation, and thawing are important processes in the manufacturing of biopharmaceuticals. By utilizing the latest single-use technologies, we can implement freezing, thawing, and transportation processes in a robust, safe, and scalable manner. In this first webinar of 2023, we will introduce Sartorius's solution "Celsius" and its features. [Seminar Overview] ▪ Date: January 24, 2023 (Tuesday) from 3:00 PM (approximately 40 minutes) ▪ Method: Webinar recorded broadcast [Japanese, free of charge] *We sincerely apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.
-
[On-Demand Streaming Available] International Webinar "Single-Use Systems for Freezing and Thawing: Advantages Compared to Conventional Bottles"
Participation in this webinar has ended. Those who wish to view it on demand can register through the details and application link. In this webinar, Marion Monstier and Sebastien Chaussin, product managers for freeze-thaw technology, will explain in detail the advantages of single-use containers compared to traditional bottles. They will also clarify important parameters to consider when validating such systems in actual processes. *Additional sessions will be held at times accommodating all time zones. We encourage you to participate and share your feedback. For those who could not attend on the day, a link to the on-demand archive will be sent to registered participants. [Main Learning Points] ▪ Advantages of single-use solutions over bottles ▪ Characteristics of single-use containers that can adapt to existing infrastructure at minimal cost ▪ Confirmation of parameters to consider when selecting single-use containers for freeze-thaw applications
-
[Sending Recorded Video] Points to Consider in the Bulk Freezing Process of Pharmaceuticals Using Single-Use Technology
Registration for this webinar has closed. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Cryopreservation technology is becoming an increasingly essential process in the management and storage of cells, viruses, and protein products during the pharmaceutical manufacturing process. Additionally, cryopreservation technology is widely used for transportation to connect manufacturing plants that are expanding globally. Recently, the necessity for ultra-low temperature transportation and storage of Covid-19 mRNA vaccines has brought attention to cryopreservation technology. Therefore, this webinar will focus on "Considerations for Freezing Processes Using Single-Use Technology." *We apologize, but participation using email addresses other than those from your company or organization is not permitted. Thank you for your understanding.
